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Introduction: Irreversible electroporation (IRE) is a promising technique for the focal treatment of soft tissue
tumors. Even though the local application of an excessive electric field is a potential cause of cardiac arrhythmias,
initial clinical studies have shown that IRE is generally safe when cardiac gating is employed.
Case description: In this case report, we observed an episode of ventricular extrasystoles without hemodynamic
changes during which time the synchronization device failed to operate properly, with pulses delivered not in the
absolute refractory period but in the relative refractory period.
Discussion and evaluation: At present, persons performing IRE must keep in mind that there is a small but real
risk of synchronization failure even when a cardiac synchronization device is used.
Conclusion: It is advisable to err on the side of caution when treating lesions near the heart.
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Irreversible electroporation (IRE) is a new non-thermal
local ablative treatment procedure in which irreversible
permeabilization of the cell membrane lipid bilayer is in-
duced by the creation of nanopores, resulting in cell
death (Davalos et al. 2005). IRE may offer two major
potential advantages over commonly employed radiofre-
quency (RF) thermal ablation approaches for the treat-
ment of hepatic lesions.
The first advantage is that, unlike RF ablation, IRE re-
lies on electrical energy rather than thermal energy to
induce cell death, and it appears to be unaffected by
nearby vessels (Rubinsky et al. 2007). This suggests that
IRE may be more effective for the treatment of areas
where tumor cells are in close proximity to large vessels
(i.e., no “heat-sink effect”). The second advantage is that
IRE may improve safety in the vicinity of heat-sensitive
structures such as blood vessels, nerves, bile ducts, and
the gastrointestinal tract (Cannon et al. 2013; Schoellnast
et al. 2013a; Choi et al. 2014; Schoellnast et al. 2013b).
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tumors.
However, specific precautions are required because the
delivery of powerful electrical pulses to human tissue
has the potential to cause fatal cardiac arrhythmias (Ball
et al. 2010). Cardiac screening and synchronized pulsing
are therefore absolutely imperative (Deodhar et al. 2011). In
an initial clinical study in which cardiac synchronization
was employed, only atrial arrhythmias occurred in 4 cases,
and these resolved spontaneously or within 24 hours after
therapy (Scheffer et al. 2014). Accordingly, initial clinical
studies have concluded that IRE may be safe when such
measures are taken (Scheffer et al. 2014).
Nonetheless, specific guidelines for the use of IRE (i.e.,
how close to the heart IRE can safely be performed even
with the use of cardiac synchronization) have not yet
been established. In this case report, we describe the IRE
treatment of metastatic liver lesions located in close
proximity to the inferior border of the heart.Case report
A 48-year-old man who had recently undergone resec-
tion of a moderately differentiated invasive adenocarcin-
oma of the rectum presented with focal liver lesionsis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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and 2 of the liver, respectively, which were newly diag-
nosed by MR imaging. No other metastatic lesions were
detected by PET. He had not a prior medical history of
other conditions, including heart disease. He had re-
ceived one cycle of modified FOLFOX6 chemotherapy
(l-leucovorin, 5-fluorouracil, and oxaliplatin), but this
treatment was halted due to adverse events such as pan-
cytopenia and malaise. He was therefore referred to our
department. After discussing treatment options, includ-
ing resection and ablation, the decision was made to
proceed with IRE for these metastases as a part of a clin-
ical trial (UMIN000014522).
We performed ultrasound (US)-guided IRE (NanoKnife;
AngioDynamics, Latham, NY, USA) with the patient under
general anesthesia with neuromuscular blockade to avoid
muscle contraction. All interventions were performed per-
cutaneously using a dedicated US system (Aplio™ 500;
Toshiba, Tochigi, Japan) equipped with a 3.75-MHz
convex transducer (PVT-385BT; Toshiba, Tochigi, Japan).
In addition, to prevent pulse-induced arrhythmias,
a preprogrammed commercial ECG trigger monitor
(AccuSync 72; AccuSync Medical Research Corporation,
Milford, CT, USA) was connected to a five-lead ECG to
synchronize pulse delivery within the refractory period of
the heart. An external biphasic defibrillator was also pre-
pared and was immediately available for the treatment of
ventricular arrhythmias.
Considering the size and shape of each lesion and includ-
ing a 1-cm tumor-free margin, we determined the number
and configuration of electrodes. The voltage was also deter-
mined using a standard algorithm (AngioDynamics) based
on factors such as the intended size of the ablation zone,
the number of probes, the distance between the probes,
and the length of the active electrode tip (Thomson et al.
2011). Accordingly, three insulated 15-cm needle electrodesFigure 1 Illustration of the IRE electrode placed near the heart. A: Sag
placed in the periphery of the hypoechoic lesion (arrowheads) in segment
(asterisk) is 1.7 cm based on US measurement. B: Sagittal B-mode US imag
of the hypoechoic lesion (arrowheads) in segment 2. The distance from the
on US measurement.with an exposure length of 20 mm were placed in the outer
border of the tumor under US guidance. All needles were
placed as parallel to one another as possible to help ensure
homogeneous energy delivery.
When we treated both lesions located in segments 4
and 2, three IRE electrodes with a separation of 1.5 to
2 cm between each pair of electrodes were used and de-
ployed in a triangular array. One of the three electrodes
was placed very close to the heart, with minimum dis-
tances from the heart of 17 mm and 10 mm, respectively
(Figure 1A, B). After a test pulse at 270 V, 10 tentative
pulses at 2250-3000 V (i.e., 1500 V/cm) with a duration
of 70 μs were delivered via each electrode pair. After
these pulses confirmed adequate conductivity, 80 add-
itional pulses were administered to reach a total of 90
pulses per electrode pair.
During ablation of the lesion in segment 4, we ob-
served an episode of ventricular extrasystoles with-
out hemodynamic changes during which time the
synchronization device failed to operate properly (i.e., un-
successful synchronization with the R wave), with pulses
delivered not in the absolute refractory period but in the
relative refractory period (Figure. 2). The arrhythmia
ceased immediately without the need to abort the proced-
ure, and IRE was continued without complications. On
the other hand, during ablation of the lesion in segment 2,
which was closest to the heart, we did not observe any ar-
rhythmias, probably because the synchronization device
operated properly (Figure. 3).
Discussion
In a previous animal study, which was conducted using
a 2-electrode configuration, all cells within a radius of
1.7 cm from each applicator were found to show a tran-
sient or permanent increase in cell membrane perme-
ability, suggesting that the delivery of IRE pulses withinittal B-mode US image demonstrates that the IRE electrode (arrow) is
4. The distance from the electrode to the inferior border of the heart
e demonstrates that the IRE electrode (arrow) is placed in the periphery
electrode to the inferior border of the heart (asterisk) is 1.0 cm based
Figure 2 Electrocardiogram during IRE treatment. A: Tracing obtained during IRE treatment of the hepatic mass in segment 4 with the
synchronization device. The distance from the electrode to the inferior border of the heart is 1.7 cm based on US measurement. IRE pulses are
incorrectly delivered on the T wave (arrows), resulting in an episode of ventricular extrasystoles (asterisks). B: The synchronization device failed to
operate properly during treatment.
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(Deodhar et al. 2011). Accordingly, the authors of that
study stated that when performing IRE ablation, in order to
avoid inducing ventricular arrhythmias, the distance from
the heart should be greater than 1.7 cm or IRE should be
performed in synchronized mode (Deodhar et al. 2011).Figure 3 Electrocardiogram during IRE treatment. A: Tracing obtained
synchronization device. The distance from the electrode to the inferior bor
correctly delivered on the R wave (arrows). B: The synchronization device oThe findings of initial clinical studies have also shown
that IRE is generally safe when cardiac gating is employed:
only minor arrhythmias occurred, with a total incidence of
2% (4 of 194) (Scheffer et al. 2014). However, in our case,
we are unable to assert the safety of this method because a
number of transient ventricular extrasystoles occurredduring IRE treatment of the hepatic mass in segment 2 with the
der of the heart is 1.0 cm based on US measurement. IRE pulses are
perated properly during treatment.
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extrasystoles occurred when the synchronization device
failed to operate properly (i.e., unsuccessful synchronization
with the R wave). As a result, some pulses were delivered
during the vulnerable period of the ventricular myocar-
dium, which corresponds to almost the entire T wave as
seen on the ECG.
Thomson et al. 2011 reported that their team used a pre-
programmed commercial ECG trigger monitor (AccuSync
42; AccuSync Medical Research Corporation) and found it
to be unsatisfactory because it lost synchronization during
IRE, causing the IRE sequence to be aborted. A more
advanced synchronization unit (AccuSync 72; AccuSync
Medical Research Corporation) was subsequently used
successfully.
Nevertheless, we have occasionally encountered such
synchronization failure (Figure. 2B) even though the
AccuSync 72 was used. Given this situation, one possible
solution is to change the lead pair in each case if
synchronization failure is observed. However, this
phenomenon is considered to be of critical importance
because it could induce ventricular arrhythmias if the
distance from the heart to the IRE electrode is less
than 1.7 cm. We feel that the manufacturer should
make further improvements to the device.
Moreover, it is important to emphasize that a 2-
electrode configuration was used in the cited study
(Deodhar et al. 2011), whereas a 3-electrode configur-
ation was used in the present study. The distance
(i.e., distance of the electrodes from the heart) could be
affected by the electrode configuration, the geometry,
and the electrical properties of the tissues. It is therefore
uncertain whether the distance obtained in this study
(i.e., 1.7 cm) is a true threshold value or not. Although a
fatal adverse event was fortunately avoided in this case,
we feel that it would be wise to avoid IRE treatment if
the heart lies in the reversibly permeabilized area until
improvements are made to the synchronization device
to avoid the possibility of synchronization failure.
In conclusion, persons performing IRE must recognize
that there is a possibility of synchronization failure. Even
when cardiac synchronization is employed, it is better to
err on the side of caution when treating lesions located
near the heart.
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